Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Steve L. Morin"'
Autor:
Cindy Geoghegan, Virginia Nido, Angie Botto-van Bemden, Zachary Hallinan, Les Jordan, Lindsay S. Kehoe, Steve L. Morin, Amanda Niskar, Petros G. Okubagzi, William A. Wood
Publikováno v:
Contemporary Clinical Trials Communications, Vol 19, Iss , Pp 100636- (2020)
In order to harness the potential of digital health technologies to enhance the quality of clinical research, it is critical to first understand how to engage patients and research sites when planning and conducting digital health trials. To pave the
Externí odkaz:
https://doaj.org/article/27cf60fec4c34b1aaae5c71d4985a82d
Autor:
Brian Perry, Cindy Geoghegan, Li Lin, F. Hunter McGuire, Virginia Nido, Brigid Grabert, Steve L. Morin, Zachary P. Hallinan, Amy Corneli
Publikováno v:
Contemporary Clinical Trials Communications, Vol 15, Iss , Pp - (2019)
The use of mobile technologies to collect participant data in clinical trials offers a number of scientific and logistical advantages. However, little is known about potential research participant preferences about how to incorporate mobile technolog
Externí odkaz:
https://doaj.org/article/0f0c74f207e048179805342fbdb9754e
Autor:
Kevin Christopher McKenna, Cindy Geoghegan, Teresa Swezey, Brian Perry, William A Wood, Virginia Nido, Steve L Morin, Brigid K Grabert, Zachary P Hallinan, Amy L Corneli
BACKGROUND The successful adoption of mobile technology for use in clinical trials relies on positive reception from key stakeholders, including clinical investigators; however, little information is known about the perspectives of investigators usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc019f3b706943a3a65f2fce3b5d635b
https://doi.org/10.2196/preprints.19242
https://doi.org/10.2196/preprints.19242
Autor:
Angie Botto-van Bemden, Petros G. Okubagzi, Zachary P Hallinan, Lindsay S. Kehoe, Virginia Nido, William A. Wood, Steve L. Morin, Cindy Geoghegan, Amanda Niskar, Les Jordan
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100636-(2020)
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100636-(2020)
In order to harness the potential of digital health technologies to enhance the quality of clinical research, it is critical to first understand how to engage patients and research sites when planning and conducting digital health trials. To pave the
Autor:
Amanda Niskar, Angie Botto-Ven Bemden, Steve L. Morin, Zachary P Hallinan, Cindy Geoghegan, William A. Wood, Petros G. Okubagzi, Lindsay S. Kehoe, Les Jordan, Virginia Nido
In order to harness the potential of mobile technologies to enhance the quality of clinical research, it is critical to first understand how to engage patients and research sites when planning and conducting mobile clinical trials. The Clinical Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd8e6e658cc7d0cca6ccde93bcb2b37
https://doi.org/10.20944/preprints201912.0203.v1
https://doi.org/10.20944/preprints201912.0203.v1
Autor:
Amy Corneli, Zachary P Hallinan, Brian Perry, Cindy Geoghegan, Steve L. Morin, F. Hunter McGuire, Brigid K Grabert, Virginia Nido, Li Lin
Publikováno v:
Contemporary Clinical Trials Communications, Vol 15, Iss, Pp-(2019)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
The use of mobile technologies to collect participant data in clinical trials offers a number of scientific and logistical advantages. However, little is known about potential research participant preferences about how to incorporate mobile technolog
Autor:
Brian Perry, William A. Wood, Zachary P Hallinan, Brigid K Grabert, Steve L. Morin, Teresa Swezey, Kevin McKenna, Virginia Nido, Amy Corneli, Cindy Geoghegan
Publikováno v:
JMIR mHealth and uHealth, Vol 9, Iss 2, p e19242 (2021)
JMIR mHealth and uHealth
JMIR mHealth and uHealth
Background The successful adoption of mobile technology for use in clinical trials relies on positive reception from key stakeholders, including clinical investigators; however, little information is known about the perspectives of investigators usin